Can scans decide who needs surgery after liver tumor shrinks?
NCT ID NCT07581769
First seen May 15, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This study looks back at 500 people with liver cancer that was too large to remove at first. After a mix of treatments (TACE, lenvatinib, and an immunotherapy drug), their tumors shrank enough to consider surgery. Researchers will use scans and medical records to see if certain patient groups do better with surgery or with continued non-surgical treatment. The goal is to find patterns that help doctors choose the best next step for each person.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiiated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
-
Zhujiang Hospital of Southern Medical University
Guangzhou, Guangdong, 510280, China
Conditions
Explore the condition pages connected to this study.